Depend if you are investing for the next CSL stock I guess and since you are hanging around you seem to be wanting to re-enter because you know the massive revenue potential of ResAppDx in the acute respiratory diagnosis and chronic respiratory management market.
RAP Price at posting:
5.4¢ Sentiment: Buy Disclosure: Held